| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1215383-78-0 | Dehydro Aripiprazole-d8 Hydrochloride | C23H18D8Cl3N3O2 |
| 1215387-58-8 | 5-Bromo-1H-pyrrolo[2,3-c]pyridine | C7H5BrN2 |
| 1215493-56-3 | N-[6-(2-Aminophenylamino)-6-oxohexyl]-4-methylbenzamide | C20H25N3O2 |
| 1215585-53-7 | 4-(Aminoiminomethyl)-1-piperazinecarboxamide hydrochloride (1:1) | C6H13N5O.HCl |
| 1215691-18-1 | N-Nitroso-N-(methyl-d3)-3-aminopropionic Acid | C4D3H5N2O3 |
| 1215692-43-5 | Tris[2-(4-methyl-5-phenyl-2-pyridinyl)phenyl]-iridium | C54H42IrN3 |
| 1215692-54-8 | Tris[2-(6-methyl-5-phenyl-2-pyridinyl)phenyl]-iridium | C54H42IrN3 |
| 1215721-40-6 | 2-[(3-Chlorophenyl)methoxy]-6-(1-piperazinyl)pyrazine hydrochloride (1:1) | C15H17ClN4O.HCl |
| 1215767-81-9 | 6-Bromo-2-chloro-8-fluoroquinoline | C9H4BrClFN |
| 1215780-15-6 | alpha-Desmethyl Anastrozole | C16H17N5 |
| 1215787-31-7 | 6-Bromo-4-chloropyrido[2,3-d]pyrimidine | C7H3BrClN3 |
| 1215794-43-6 | [4-(4-Ethylcyclohexyl)-2-fluorophenyl]boronic acid | C14H20BFO2 |
| 1215797-86-6 | 4,5,6,7-Tetrahydro-1-methyl-1H-imidazo[4,5-c]pyridine hydrochloride | C7H11N3.HCl |
| 1215807-38-7 | rac-Mirabegron-d5 | C21H19D5N4O2S |
| 1215857-68-3 | 2-(2-Hexyldecyl)thiophene | C20H36S |
| 1215876-95-1 | 1,1',1''-(9,10-Dihydro-9,10[1',2']-benzenoanthracene-2,6,14-triyl)tris[1,1-diphenylphosphine oxide] | C56H41O3P3 |
| 1216113-27-7 | 3-Chloro-1H-indole-4-carboxaldehyde | C9H6ClNO |
| 1216141-63-7 | 3-(Methylsulfonyl)propanimidamide | C4H10N2O2S |
| 1216142-18-5 | 6-Chloro-2-ethylimidazo[1,2-a]pyridine-3-carboxylic acid | C10H9ClN2O2 |
| 1216406-90-4 | 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester ethanedioate (1:1) | C20H23ClN2O5.C2H2O4 |
| 1216474-94-0 | 5-Bromo-4,6-dichloronicotinic acid | C6H2BrCl2NO2 |
| 1216539-56-8 | DL-Venlafaxine-d10 Hydrochloride | C17H17D10NO2.HCl |
| 1216665-49-4 | N2-1H-Benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine | C17H16N8 |
| 1216682-38-0 | Lansoprazole Sulfide-d4 | C16H10D4F3N3OS |
| 1216720-69-2 | N3-Cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine hydrochloride (1:2) | C23H25N5.2(HCl) |
| 1216737-36-8 | Nicotinuric acid-d4 | C8H4D4N2O3 |
| 1216739-35-3 | Bumetanide-d5 | C17H15D5N2O5S |
| 1216815-21-2 | 3-(Bromomethyl)-2-oxa-8-azaspiro[4.5]decane-8-carboxylic acid 1,1-dimethylethyl ester | C14H24BrNO3 |
| 1216893-18-3 | 2-(3-Chlorophenyl)-3-methyl-5,5-bis(trideuteriomethyl)morpholin-2-ol | C13H12ClD6NO2 |
| 1216898-82-6 | Anastrozole Dimer Impurity | C30H31N9 |
| 1216908-63-2 | AR-AO 14418-d3 | C12H12N4O4S |
| 1216936-29-6 | tert-Butyl 1,7-diazaspiro[3.5]nonane-1-carboxylate | C12H22N2O2 |
| 1216941-40-0 | N-[(2R,6S,12Z,13aS,14aR,16aS)-14a-[[(Cyclopropylsulfonyl)amino]carbonyl]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxo-2-(6-phenanthridinyloxy)cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl]carbamic acid 1,1-dimethylethyl ester | C39H47N5O8S |
| 1216941-48-8 / 1221573-85-8 | Paritaprevir | C40H43N7O7S |
| 1216941-64-8 | (2S,6S,12Z,13aS,14aR,16aS)-2-[[(4-Bromophenyl)sulfonyl]oxy]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid ethyl ester | C31H42BrN3O9S |
| 1216941-72-8 | (2R,6S,12Z,13aS,14aR,16aS)-6-[[(1,1-Dimethylethoxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-2-(6-phenanthridinyloxy)-cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid ethyl ester | C38H46N4O7 |
| 1216941-73-9 | (2R,6S,12Z,13aS,14aR,16aS)-6-[[(1,1-Dimethylethoxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-2-(6-phenanthridinyloxy)-cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid | C36H42N4O7 |
| 1216941-74-0 | (2R,6S,12Z,13aS,14aR,16aS)-6-Amino-N-(cyclopropylsulfonyl)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-2-(6-phenanthridinyloxy)-cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide hydrochloride (1:1) | C34H39N5O6S.HCl |
| 1216941-97-7 | N-[(5-Methyl-2-pyrazinyl)carbonyl]-6-(2-propen-1-yl)-L-norleucine | C15H21N3O3 |
| 1216951-05-1 | 7-Methyl-1H-indazol-5-amine hydrochloride (1:1) | C8H9N3.HCl |
| 1217169-93-1 | Amiloride 15N3 | C6H8ClN7O |
| 1217214-94-2 | Desfluoro Fluvoxamine | C15H22F2N2O2 |
| 1217220-85-3 | Nitrofurazone-13C,15N2 | C6H6N4O4 |
| 1217222-76-8 | Furazolidone-d4 | C8H3D4N3O5 |
| 1217226-46-4 | Nitrofurantoin-13C3 | C8H6N4O5 |
| 1217241-15-0 | Fluvoxamine EP Impurity J | C17H17F3N2O |
| 1217245-60-7 | 3-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-N-(1-methylethyl)-2-Propen-1-amine | C18H29NO3 |
| 1217262-11-7 | N-(Ethylamino) Fluvoxamine | C17H26F3N3O2 |
| 1217295-84-5 | 4-Pyridazineacetic acid lithium salt | C6H5N2O2.Li |
| 1217305-03-7 | N-(4-Bromo-5-fluoro-2-nitrophenyl)acetamide | C8H6BrFN2O3 |